Provided by Tiger Trade Technology Pte. Ltd.

Eco Wave Power Global AB (publ)

5.02
-0.0300-0.59%
Post-market: 5.020.00000.00%16:10 EST
Volume:9.44K
Turnover:47.64K
Market Cap:29.30M
PE:-8.57
High:5.38
Open:5.01
Low:4.90
Close:5.05
52wk High:9.87
52wk Low:4.41
Shares:5.84M
Float Shares:2.92M
Volume Ratio:1.08
T/O Rate:0.32%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.5860
EPS(LYR):-0.3734
ROE:-56.50%
ROA:-20.34%
PB:4.66
PE(LYR):-13.44

Loading ...

Eco Wave Power Advances 8.3 MW Wave Energy Project at Port of Ngqura

Reuters
·
Yesterday

Eco Wave Power Reports Stable Wave Energy Production at Jaffa Port in January 2026

Reuters
·
Feb 12

Eco Wave Power Signs Financing LOI with Wavefront Asset Management

Reuters
·
Feb 10

Eco Wave Power Advances 1 MW Wave Energy Project in Porto

Reuters
·
Jan 15

Eco Wave Power Launches Wave Energy Project at Port of Los Angeles

Reuters
·
Jan 12

Eco Wave Power Reports Strong December 2025 Wave Energy Production at Jaffa Port

Reuters
·
Jan 12

Press Release: Worthington Enterprises Declares Quarterly Dividend; Charles Chiappone Joins Board of Directors

Dow Jones
·
Dec 17, 2025

U.S. Small Caps Close Mixed As WAVE Life Sciences Leads, New Found Gold Lags

Dow Jones
·
Dec 09, 2025

Eco Wave Power Global (WAVE) Receives a Buy from Maxim Group

TIPRANKS
·
Nov 19, 2025

Eco Wave Power Global AB reports Q3 net loss of $996 thousand on increased investment in U.S. project launch

Reuters
·
Nov 12, 2025

Did Positive WAVE Trial Results and Global Approvals Just Shift Merit Medical Systems' (MMSI) Investment Narrative?

Simply Wall St.
·
Nov 11, 2025

WAVE Life Sciences Q3 EPS $(0.32) Misses $(0.30) Estimate, Sales $7.608M Miss $11.130M Estimate

Benzinga
·
Nov 10, 2025

Eco Wave Power Global AB (publ) expected to post a loss of 14 cents a share - Earnings Preview

Reuters
·
Nov 07, 2025

Merit Medical Releases 24-Month Efficacy Results from the Randomized Arteriovenous Fistula (AVF) Arm of the WRAPSODY Arteriovenous Access Efficacy (WAVE) Trial

GlobeNewswire
·
Nov 05, 2025

Merit Medical releases efficacy results from single-arm AVG cohort of WAVE trial

TIPRANKS
·
Nov 03, 2025

Merit Medical Releases 24-Month Efficacy Results from the Single-Arm Arteriovenous Graft (AVG) Cohort of the WRAPSODY Arteriovenous Access Efficacy (WAVE) Trial

GlobeNewswire
·
Nov 03, 2025

Eco Wave Power Unveils First U.S. Onshore Wave Energy Pilot in Los Angeles, Highlighting $1B Federal Push for Marine Renewables

Reuters
·
Oct 07, 2025

Eco Wave Power Global Ab (Publ) : Alliance Global Partners Resumes Coverage With Buy Rating; Price Target $14.5

THOMSON REUTERS
·
Sep 29, 2025

Eco Wave Power Launches First U.S. Wave Energy Project at Port of Los Angeles, Paving Way for Global Expansion

Reuters
·
Sep 10, 2025

Small U.S. Stocks Close Lower; WAVE Life Sciences Takes Biggest Hit

Dow Jones
·
Sep 04, 2025